UK markets closed

BeiGene Ltd (49BA.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
152.000.00 (0.00%)
At close: 08:05AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,762,630
2,458,779
1,415,921
1,176,283
308,874
-
Cost of revenue
423,066
379,920
286,475
164,906
70,657
-
Gross profit
2,339,564
2,078,859
1,129,446
1,011,377
238,217
-
Operating expenses
Research development
1,830,648
1,778,594
1,640,508
1,459,239
1,294,877
-
Selling general and administrative
1,603,429
1,504,501
1,277,852
990,123
600,176
-
Total operating expenses
3,437,390
3,286,595
2,919,111
2,450,112
1,895,899
-
Operating income or loss
-1,097,826
-1,207,736
-1,789,665
-1,438,735
-1,657,682
-
Total other income/expenses net
291,350
307,891
-223,852
15,904
37,490
-
Income before tax
-732,323
-825,836
-1,961,037
-1,438,588
-1,618,194
-
Income tax expense
52,104
55,872
42,778
19,228
10,397
-
Income from continuing operations
-784,427
-881,708
-2,003,815
-1,457,816
-1,628,591
-
Net income
-784,427
-881,708
-2,003,815
-1,457,816
-1,624,974
-
Net income available to common shareholders
-784,427
-881,708
-2,003,815
-1,457,816
-1,624,974
-
Basic EPS
-9.23
-
-19.37
-15.21
-19.11
-15.86
Diluted EPS
-9.23
-
-19.37
-15.21
-19.11
-15.86
Basic average shares
104,311
-
103,133
92,785
83,472
60,054
Diluted average shares
104,311
-
103,133
92,785
83,472
60,054